openPR Logo
Press release

Investigation announced for Long-Term Investors in Apyx Medical Corporation (NASDAQ: APYX) over potential Wrongdoing

09-30-2022 01:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Apyx Medical Corporation (NASDAQ: APYX) shares.

An investigation on behalf of current long term investors in Apyx Medical Corporation (NASDAQ: APYX) shares.

An investigation on behalf of current long-term investors in shares of Apyx Medical Corporation (NASDAQ: APYX) concerning potential breaches of fiduciary duties by certain directors and officers of Apyx Medical Corporation was announced.

Investors who are current long term investors in Apyx Medical Corporation (NASDAQ: APYX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: APYX stocks follows a lawsuit filed against Apyx Medical Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: APYX stocks, concerns whether certain Apyx Medical Corporation directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Middle District of Florida the plaintiff alleges that the Defendants failed to disclose to investors that a significant number of Apyx's Advanced Energy products were used for off-label indications, that such off-label uses led to an increase in the number of medical device reports filed by Apyx Medical Corporation reporting serious adverse events, that, as a result, the Company was reasonably likely to incur regulatory scrutiny, that, as a result of the foregoing, the Company's financial results would be adversely impacted, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis

Those who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Apyx Medical Corporation (NASDAQ: APYX) over potential Wrongdoing here

News-ID: 2754186 • Views: 323

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of FOXO Technologies Inc. (NYSE …
An investigation was announced for investors of FOXO Technologies Inc. (NYSE American: FOXO) shares over potential securities laws violations by FOXO Technologies Inc. Investors who purchased shares of FOXO Technologies Inc. (NYSE American: FOXO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by FOXO Technologies Inc. regarding its business, its
Lawsuit filed for Investors who lost Money with shares of Unisys Corporation (NY …
An investor, who purchased shares of Unisys Corporation (NYSE: UIS), filed a lawsuit over alleged violations of Federal Securities Laws by Unisys Corporation. Investors who purchased shares of Unisys Corporation (NYSE: UIS) have certain options and for certain investors are short and strict deadlines running. Deadline: January 10, 2023. NYSE: UIS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Blue Bell, PA based Unisys Corporation, together
Investigation announced for Investors in shares of KB Home (NYSE: KBH)
An investigation was announced over potential securities laws violations by KB Home in connection with certain financial statements. Investors who purchased shares of KB Home (NYSE: KBH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on whether a series of statements by KB Home regarding its business, its prospects and its operations were
Lawsuit filed for Investors in shares of Enviva Inc. (NYSE: EVA) over alleged Se …
An investor, who purchased shares of Enviva Inc. (NYSE: EVA), filed a lawsuit over alleged violations of Federal Securities Laws by Enviva Inc. formerly known as Enviva Partners, LP. Investors who purchased shares of Enviva Inc. (NYSE: EVA) have certain options and for certain investors are short and strict deadlines running. Deadline: January 2, 2023. NYSE: EVA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Bethesda,

All 5 Releases


More Releases for Apyx

Lawsuit filed for Investors in shares of Apyx Medical Corporation (NASDAQ: APYX)
An investor, who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), filed a lawsuit over alleged violations of Federal Securities Laws by Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: APYX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Clearwater FL based Apyx
Investigation announced for Investors in shares of Apyx Medical Corporation (NAS …
An investigation was announced over potential securities laws violations by Apyx Medical Corporation in connection with certain financial statements. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Apyx Medical Corporation regarding its business, its prospects and its operations were
Cold Plasma Market Comprehensive Analysis Reveals Superb Growth | Apyx Medical C …
The market report provides a recent estimate and forecast for the global Cold Plasma Market at the global, corporate, and regional levels. The report offers a detailed overview of global demand for Cold Plasma Market from 2016 to 2028, with 2016 as the base year and 2028 as the projected end date. Data for 2016-2028 has been included, along with information and analyses of previous results. The market study discusses
Global Cold Plasma Market Opportunity Assessment 2021-2026 ||Apyx Medical Corpor …
Advance Market Analytics published a new research publication on "Cold Plasma Market Insights, to 2026" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market stakeholders. The growth of the Cold Plasma market is mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy
Investigation announced for Long-Term Investors in Apyx Medical Corporation (NAS …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Apyx Medical Corporation. Investors who purchased shares of Apyx Medical Corporation (NASDAQ: APYX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Apyx Medical directors breached their fiduciary duties and caused damage to the company and its shareholders. Clearwater, FL
Cold Plasma Equipment Market Key Market Opportunities and Future Trends - Plasma …
Cold plasma is proved very effective in the biomedicine. Cold plasma is used in many medical treatments such as, wound healing, cancer, dermatology, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, and inflammation, disinfection and scar treatment. Cold plasma's ability to kill bacteria, including the drug-resistant bacteria, to avoid further infection, helps in chronic wounds. This accelerates the process of wound healing and prevents further complications and the related discomforts.